Stroke Trial, Recruiting NCT03552926 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT03552926
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have had a recent neurological problem (such as weakness, numbness, or difficulty speaking) that started less than 15 days ago, caused by a small stroke in a deep part of the brain
  • People whose brain MRI scan confirms a recent small, deep stroke (a small area of damage, less than 20mm wide, in the territory supplied by one small blood vessel) that matches their symptoms
  • People who are able to attend follow-up appointments and yearly brain check-ups
  • People who are covered by the French national health insurance (Sécurité Sociale)
  • People who have signed a consent form agreeing to take part in the trial

Who may not be able to join:

  • People who have previously been diagnosed with dementia (based on specific recognised diagnostic standards)
  • People who already had a significant level of disability before this stroke, meaning they required considerable help with daily activities (confirm with trial site)
  • People with a serious ongoing illness in another part of the body that could make it difficult to complete the study
  • People whose white matter brain changes (shown on scans) are caused by something other than blood vessel disease
  • People with a severe mental health condition
  • People from whom a signed consent form cannot be obtained, either from the patient or a family member
  • People for whom an MRI brain scan is medically unsafe or who are not willing to have one

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Eric JOUVENT, MD, PhD, Assistance Publique - Hôpitaux de Paris

Phone: 33 1 49 95 65 29

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 June 2018
Est. completion
30 August 2022

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Time to the occurrence of cognitive decline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov